Jatropha Genome Database
- JcCA0312681.20
BLASTP 2.2.23 [Feb-03-2010]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= JcCA0312681.20 - phase: 0
(241 letters)
Database: Medicago_aa3.0
53,423 sequences; 12,992,982 total letters
Searching..................................................done
Score E
Sequences producing significant alignments: (bits) Value
IMGA|Medtr7g121350.1 Beta-Ig-H3/fasciclin chr07_pseudomolecule_I... 244 2e-65
IMGA|Medtr4g081470.1 Beta-Ig-H3/fasciclin chr04_pseudomolecule_I... 195 2e-50
IMGA|Medtr2g110620.1 Beta-Ig-H3/fasciclin chr02_pseudomolecule_I... 181 4e-46
IMGA|Medtr4g135790.1 Beta-Ig-H3/fasciclin chr04_pseudomolecule_I... 161 2e-40
IMGA|Medtr2g021660.1 Beta-Ig-H3/fasciclin; Lipocalin chr02_pseud... 160 4e-40
IMGA|Medtr4g135820.1 Beta-Ig-H3/fasciclin chr04_pseudomolecule_I... 160 4e-40
IMGA|Medtr4g069920.1 Beta-Ig-H3/fasciclin chr04_pseudomolecule_I... 146 8e-36
IMGA|Medtr4g069630.1 Beta-Ig-H3/fasciclin chr04_pseudomolecule_I... 146 8e-36
IMGA|Medtr2g110630.1 Beta-Ig-H3/fasciclin chr02_pseudomolecule_I... 145 2e-35
IMGA|Medtr4g081330.1 Beta-Ig-H3/fasciclin chr04_pseudomolecule_I... 144 3e-35
IMGA|AC235673_3.1 Beta-Ig-H3/fasciclin AC235673.1 9318-10421 F E... 144 4e-35
IMGA|Medtr4g081390.1 Beta-Ig-H3/fasciclin chr04_pseudomolecule_I... 144 4e-35
IMGA|Medtr4g081380.1 Beta-Ig-H3/fasciclin chr04_pseudomolecule_I... 143 6e-35
IMGA|Medtr4g135780.1 Beta-Ig-H3/fasciclin chr04_pseudomolecule_I... 141 2e-34
IMGA|Medtr2g021680.1 Beta-Ig-H3/fasciclin chr02_pseudomolecule_I... 140 6e-34
IMGA|Medtr2g021670.1 Beta-Ig-H3/fasciclin chr02_pseudomolecule_I... 139 1e-33
IMGA|Medtr2g110640.1 Beta-Ig-H3/fasciclin chr02_pseudomolecule_I... 137 6e-33
IMGA|Medtr5g105700.1 Beta-Ig-H3/fasciclin chr05_pseudomolecule_I... 105 2e-23
IMGA|Medtr5g106070.1 Beta-Ig-H3/fasciclin chr05_pseudomolecule_I... 66 2e-11
IMGA|Medtr2g021940.1 Beta-Ig-H3/fasciclin chr02_pseudomolecule_I... 52 2e-07
>IMGA|Medtr7g121350.1 Beta-Ig-H3/fasciclin
chr07_pseudomolecule_IMGAG_V3 28555618-28554583 E
EGN_Mt090430 20090702
Length = 283
Score = 244 bits (624), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 118/158 (74%), Positives = 139/158 (87%)
Query: 28 SPAPSGPTNITAILEKAGQFTTFIKLMKSTQEADQINTQLNNSNQGLTVFAPPDNAFANL 87
SPAPSGP NIT +LEKAGQFTTFIKL+K+TQ +D+IN+QLNNSNQGLT+FAP DNAF++L
Sbjct: 32 SPAPSGPLNITKVLEKAGQFTTFIKLLKATQVSDRINSQLNNSNQGLTIFAPTDNAFSSL 91
Query: 88 KPGTLNSLTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNVTTSGNQ 147
K GTLNS++ Q ++QL+QFHILP+ +SQFQT SNPL TQAGNS +GE+PLNVTTSGNQ
Sbjct: 92 KSGTLNSISTQNQLQLLQFHILPTLYTISQFQTASNPLHTQAGNSDDGEYPLNVTTSGNQ 151
Query: 148 VNVTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDLFG 185
VNVTTGV TV+NTIY+D LAVYQVDQVLLP+ LFG
Sbjct: 152 VNVTTGVIDTTVSNTIYSDNQLAVYQVDQVLLPMALFG 189
>IMGA|Medtr4g081470.1 Beta-Ig-H3/fasciclin
chr04_pseudomolecule_IMGAG_V3 17002379-17001197 E
EGN_Mt090430 20090702
Length = 250
Score = 195 bits (495), Expect = 2e-50, Method: Compositional matrix adjust.
Identities = 98/163 (60%), Positives = 129/163 (79%), Gaps = 4/163 (2%)
Query: 25 QNPSPAPS---GPTNITAILEKAGQFTTFIKLMKSTQEADQINTQLNNSNQGLTVFAPPD 81
++P+PAPS PT+I IL+KAG FTT I+L+++TQ + QIN+QL NSN GLT+FAP D
Sbjct: 28 KSPAPAPSTDTAPTDIIRILKKAGGFTTLIRLLQTTQVSTQINSQLLNSNGGLTLFAPND 87
Query: 82 NAFANLKPGTLNSLTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNV 141
N+F++LKPG LNSL+D+ K +L+QFH+LP+F++MS F T+SNP+RTQAG+ LNV
Sbjct: 88 NSFSSLKPGFLNSLSDEQKNKLIQFHLLPTFVSMSNFDTLSNPVRTQAGDDPY-RLGLNV 146
Query: 142 TTSGNQVNVTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDLF 184
T+SGNQVN+TTG+ TV T+YTD LAVYQVD+VLLP D F
Sbjct: 147 TSSGNQVNMTTGIVNVTVGGTVYTDHQLAVYQVDKVLLPRDFF 189
>IMGA|Medtr2g110620.1 Beta-Ig-H3/fasciclin
chr02_pseudomolecule_IMGAG_V3 26078830-26079943 E
EGN_Mt090430 20090702
Length = 250
Score = 181 bits (458), Expect = 4e-46, Method: Compositional matrix adjust.
Identities = 91/150 (60%), Positives = 116/150 (77%), Gaps = 1/150 (0%)
Query: 35 TNITAILEKAGQFTTFIKLMKSTQEADQINTQLNNSNQGLTVFAPPDNAFANLKPGTLNS 94
T+I IL+KAG FTT I+L+++TQ A QIN QL NSN GLT+FAP DN+F+ LKPG LNS
Sbjct: 40 TDIIRILKKAGGFTTLIRLLQTTQVATQINAQLLNSNNGLTLFAPNDNSFSTLKPGFLNS 99
Query: 95 LTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNVTTSGNQVNVTTGV 154
L DQ K +L+QFH LPSF+A+S F T+SNP+RTQAG+ LN+T+SG QVN+TTGV
Sbjct: 100 LNDQQKNELIQFHELPSFVALSNFDTLSNPVRTQAGDDPE-RLALNITSSGTQVNLTTGV 158
Query: 155 DTATVANTIYTDGSLAVYQVDQVLLPLDLF 184
ATV ++++D LA+YQVD+VLLP D F
Sbjct: 159 VNATVGGSVFSDHQLAIYQVDKVLLPKDFF 188
>IMGA|Medtr4g135790.1 Beta-Ig-H3/fasciclin
chr04_pseudomolecule_IMGAG_V3 33095523-33096795 E
EGN_Mt090430 20090702
Length = 316
Score = 161 bits (408), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 90/168 (53%), Positives = 123/168 (73%), Gaps = 10/168 (5%)
Query: 24 AQNPSP---APSGPT-NITAILEKAGQFTTFIKLMKSTQEADQINTQLNNS---NQGLTV 76
A PSP P GPT +I IL+KA +F+ I+L+K+TQ +Q+N+QL +S + GLT+
Sbjct: 77 AGAPSPTITVPKGPTIDIINILQKAKRFSVLIRLLKTTQLINQLNSQLVSSPSGSGGLTI 136
Query: 77 FAPPDNAFANLKPGTLNSLTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGE 136
FAP D+AF+ LK G LNSLTD+ KV+L+QFH L SF+++S F T++NP++TQAG+ A
Sbjct: 137 FAPEDSAFSKLKAGFLNSLTDRQKVELLQFHSLASFVSISNFDTLTNPVQTQAGDDA--R 194
Query: 137 FPLNVTT-SGNQVNVTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDL 183
LNVTT G+QV++ TG ATV T+YTD LA+YQVD+VL+PLDL
Sbjct: 195 LQLNVTTYGGSQVSMATGAVNATVTGTVYTDSKLAIYQVDKVLMPLDL 242
>IMGA|Medtr2g021660.1 Beta-Ig-H3/fasciclin; Lipocalin
chr02_pseudomolecule_IMGAG_V3 5558474-5557277 E
EGN_Mt090430 20090702
Length = 295
Score = 160 bits (406), Expect = 4e-40, Method: Compositional matrix adjust.
Identities = 89/168 (52%), Positives = 124/168 (73%), Gaps = 9/168 (5%)
Query: 24 AQNPSPAPSGPT-NITAILEKAGQFTTFIKLMKSTQEADQINTQL------NNSNQGLTV 76
A P+ P P+ +I IL+KA +F+ I+L+K+TQ +Q+N+QL ++S+ GLT+
Sbjct: 58 APTPNILPKSPSIDIIQILKKAKRFSVLIRLLKTTQLINQLNSQLVTSSSSDSSSGGLTL 117
Query: 77 FAPPDNAFANLKPGTLNSLTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGE 136
FAP DNAF+ LKPG LNSL+D+ KV+L+QFH L SFI++S F T++NP++TQAG+ A
Sbjct: 118 FAPEDNAFSKLKPGFLNSLSDRHKVELLQFHTLSSFISISNFDTLTNPVQTQAGDDAK-R 176
Query: 137 FPLNVTTS-GNQVNVTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDL 183
LNVTTS G+ V++TTG ATV T+YTD LA+YQVD+VL+PLDL
Sbjct: 177 LQLNVTTSGGSHVSMTTGTVNATVTGTVYTDNKLAIYQVDKVLVPLDL 224
>IMGA|Medtr4g135820.1 Beta-Ig-H3/fasciclin
chr04_pseudomolecule_IMGAG_V3 33098911-33100080 E
EGN_Mt090430 20090702
Length = 316
Score = 160 bits (406), Expect = 4e-40, Method: Compositional matrix adjust.
Identities = 89/165 (53%), Positives = 122/165 (73%), Gaps = 10/165 (6%)
Query: 27 PSP---APSGPT-NITAILEKAGQFTTFIKLMKSTQEADQINTQLNNS---NQGLTVFAP 79
PSP P GPT +I IL+KA +F+ I+L+K+TQ +Q+N+QL +S + GLT+FAP
Sbjct: 80 PSPTITVPKGPTIDIINILQKAKRFSVLIRLLKTTQLINQLNSQLVSSPSGSGGLTIFAP 139
Query: 80 PDNAFANLKPGTLNSLTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPL 139
D+AF+ LK G LNSLTD+ KV+L+QFH L SF+++S F T++NP++TQAG+ A L
Sbjct: 140 EDSAFSKLKAGFLNSLTDRQKVELLQFHSLASFVSISNFDTLTNPVQTQAGDDA--RLQL 197
Query: 140 NVTT-SGNQVNVTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDL 183
NVTT G+QV++ TG ATV T+YTD LA+YQVD+VL+PLDL
Sbjct: 198 NVTTYGGSQVSMATGAVNATVTGTVYTDSKLAIYQVDKVLMPLDL 242
>IMGA|Medtr4g069920.1 Beta-Ig-H3/fasciclin
chr04_pseudomolecule_IMGAG_V3 13457474-13458797 E
EGN_Mt090430 20090702
Length = 296
Score = 146 bits (369), Expect = 8e-36, Method: Compositional matrix adjust.
Identities = 74/160 (46%), Positives = 107/160 (66%), Gaps = 2/160 (1%)
Query: 26 NPSPAPSGPTNITAILEKAGQFTTFIKLMKSTQEADQINTQL-NNSNQGLTVFAPPDNAF 84
+ +P SG +I IL KA F I+LMK+TQ +Q+N+QL + GLT+ AP DNAF
Sbjct: 67 DSTPDSSGAVDIVGILRKAKSFNVLIRLMKTTQLINQLNSQLLATKSGGLTILAPDDNAF 126
Query: 85 ANLKPGTLNSLTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNVTTS 144
+ LK G LNSL+D K++L+QFH++ +++ S F T++NP+RT AG + G+ LNV +
Sbjct: 127 SQLKAGFLNSLSDGQKLELLQFHVISDYVSSSNFDTLTNPVRTLAG-AKPGKVELNVISY 185
Query: 145 GNQVNVTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDLF 184
G VN++TG T+ IYTD LA+Y+V +VLLP+D F
Sbjct: 186 GGSVNISTGEVNTTIDGIIYTDKRLAIYKVGKVLLPMDFF 225
>IMGA|Medtr4g069630.1 Beta-Ig-H3/fasciclin
chr04_pseudomolecule_IMGAG_V3 13329978-13331301 F
EGN_Mt090430 20090702
Length = 296
Score = 146 bits (369), Expect = 8e-36, Method: Compositional matrix adjust.
Identities = 74/160 (46%), Positives = 107/160 (66%), Gaps = 2/160 (1%)
Query: 26 NPSPAPSGPTNITAILEKAGQFTTFIKLMKSTQEADQINTQL-NNSNQGLTVFAPPDNAF 84
+ +P SG +I IL KA F I+LMK+TQ +Q+N+QL + GLT+ AP DNAF
Sbjct: 67 DSTPDSSGAVDIVGILRKAKSFNVLIRLMKTTQLINQLNSQLLATKSGGLTILAPDDNAF 126
Query: 85 ANLKPGTLNSLTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNVTTS 144
+ LK G LNSL+D K++L+QFH++ +++ S F T++NP+RT AG + G+ LNV +
Sbjct: 127 SQLKAGFLNSLSDGQKLELLQFHVISDYVSSSNFDTLTNPVRTLAG-AKPGKVELNVISY 185
Query: 145 GNQVNVTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDLF 184
G VN++TG T+ IYTD LA+Y+V +VLLP+D F
Sbjct: 186 GGSVNISTGEVNTTIDGIIYTDKRLAIYKVGKVLLPMDFF 225
>IMGA|Medtr2g110630.1 Beta-Ig-H3/fasciclin
chr02_pseudomolecule_IMGAG_V3 26081198-26082302 E
EGN_Mt090430 20090702
Length = 271
Score = 145 bits (365), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 72/160 (45%), Positives = 108/160 (67%), Gaps = 2/160 (1%)
Query: 27 PSPAPSGPTNITAILEKAGQFTTFIKLMKSTQEADQINTQLNNSNQG-LTVFAPPDNAFA 85
P + S P +IT IL+KA FT +L+++TQ D +N+QL ++ G LT+ AP D+AF+
Sbjct: 47 PDTSDSTPDDITKILKKAKTFTILTRLLRTTQIVDNLNSQLISAKSGGLTILAPDDSAFS 106
Query: 86 NLKPGTLNSLTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNVTTSG 145
+LK G NSL + K++L+QFHILP F+ + F ++SNP+ T AG + PLN+ + G
Sbjct: 107 HLKAGFFNSLNENKKIELLQFHILPQFVDSNNFDSLSNPVETVAGKDP-LKLPLNIESFG 165
Query: 146 NQVNVTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDLFG 185
V+++TGV A+V +Y D LA+Y++D+VLLPLD FG
Sbjct: 166 TSVSLSTGVVNASVTGVVYQDNKLAIYRLDKVLLPLDFFG 205
>IMGA|Medtr4g081330.1 Beta-Ig-H3/fasciclin
chr04_pseudomolecule_IMGAG_V3 16960686-16961627 E
EGN_Mt090430 20090702
Length = 292
Score = 144 bits (364), Expect = 3e-35, Method: Compositional matrix adjust.
Identities = 72/160 (45%), Positives = 107/160 (66%), Gaps = 2/160 (1%)
Query: 26 NPSPAPSGPTNITAILEKAGQFTTFIKLMKSTQEADQINTQL-NNSNQGLTVFAPPDNAF 84
+ +P +G +I IL KA F FI+LMK+TQ +Q+N+QL GLT+ AP D+AF
Sbjct: 63 DSTPDTAGTVDIVGILRKAKAFNVFIRLMKTTQLINQLNSQLLATKTGGLTILAPDDSAF 122
Query: 85 ANLKPGTLNSLTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNVTTS 144
+ LK G LNSL+D K++L+QFH++ +++ S F T++NP+RT AG+ G+ LNV +
Sbjct: 123 SGLKAGFLNSLSDGQKLELLQFHVISDYVSSSNFDTLTNPVRTLAGDKP-GKVELNVVSY 181
Query: 145 GNQVNVTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDLF 184
G VN++TG T+ +YTD LA+Y+V +VLLP+D F
Sbjct: 182 GGSVNISTGEVNTTINGIVYTDKRLAIYKVGKVLLPMDFF 221
>IMGA|AC235673_3.1 Beta-Ig-H3/fasciclin AC235673.1 9318-10421 F
EGN_Mt090430 20090702
Length = 280
Score = 144 bits (363), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 77/162 (47%), Positives = 110/162 (67%), Gaps = 2/162 (1%)
Query: 25 QNPSPAPSGPTNITAILEKAGQFTTFIKLMKSTQEADQINTQL-NNSNQGLTVFAPPDNA 83
++P S P +IT IL+KA F+ I+L+K+T+ +N+QL N GLT+ AP D+A
Sbjct: 56 ESPDSTDSVPDDITTILKKAKTFSVLIRLLKTTEIMSSVNSQLITAKNGGLTILAPDDSA 115
Query: 84 FANLKPGTLNSLTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNVTT 143
F++LK G LNSL + K++L+QFHILP ++A S F ++SNP++T AG PLNV
Sbjct: 116 FSSLKAGFLNSLDENKKIELLQFHILPQYVASSNFDSLSNPVQTIAGKDPT-RLPLNVYA 174
Query: 144 SGNQVNVTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDLFG 185
SGN V+++TGV TA+V +YTD LA+Y +D+VLLP D F
Sbjct: 175 SGNNVSLSTGVVTASVVGVVYTDNKLAIYHLDKVLLPRDFFA 216
>IMGA|Medtr4g081390.1 Beta-Ig-H3/fasciclin
chr04_pseudomolecule_IMGAG_V3 16981035-16979934 F
EGN_Mt090430 20090702
Length = 280
Score = 144 bits (363), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 77/162 (47%), Positives = 110/162 (67%), Gaps = 2/162 (1%)
Query: 25 QNPSPAPSGPTNITAILEKAGQFTTFIKLMKSTQEADQINTQL-NNSNQGLTVFAPPDNA 83
++P S P +IT IL+KA F+ I+L+K+T+ +N+QL N GLT+ AP D+A
Sbjct: 56 ESPDSTDSVPDDITTILKKAKTFSVLIRLLKTTEIMSSVNSQLITAKNGGLTILAPDDSA 115
Query: 84 FANLKPGTLNSLTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNVTT 143
F++LK G LNSL + K++L+QFHILP ++A S F ++SNP++T AG PLNV
Sbjct: 116 FSSLKAGFLNSLDENKKIELLQFHILPQYVASSNFDSLSNPVQTIAGKDPT-RLPLNVYA 174
Query: 144 SGNQVNVTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDLFG 185
SGN V+++TGV TA+V +YTD LA+Y +D+VLLP D F
Sbjct: 175 SGNNVSLSTGVVTASVVGVVYTDNKLAIYHLDKVLLPRDFFA 216
>IMGA|Medtr4g081380.1 Beta-Ig-H3/fasciclin
chr04_pseudomolecule_IMGAG_V3 16977802-16976621 F
EGN_Mt090430 20090702
Length = 291
Score = 143 bits (361), Expect = 6e-35, Method: Compositional matrix adjust.
Identities = 72/158 (45%), Positives = 106/158 (67%), Gaps = 2/158 (1%)
Query: 28 SPAPSGPTNITAILEKAGQFTTFIKLMKSTQEADQINTQL-NNSNQGLTVFAPPDNAFAN 86
+P +G +I IL KA + FI+LMK+TQ +Q+N+QL GLT+ AP D+AF+
Sbjct: 65 TPDTAGTVDIVGILRKAKAYNVFIRLMKTTQLINQLNSQLLATKTGGLTILAPDDSAFSG 124
Query: 87 LKPGTLNSLTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNVTTSGN 146
LK G LNSL+D K++L+QFH++ +++ S F T++NP+RT AG+ G+ LNV + G
Sbjct: 125 LKAGFLNSLSDGQKLELLQFHVISDYVSSSNFDTLTNPVRTLAGDKP-GKVELNVVSYGG 183
Query: 147 QVNVTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDLF 184
VN++TG T+ IYTD LA+Y+V +VLLP+D F
Sbjct: 184 SVNISTGEVNTTINGIIYTDKRLAIYKVGKVLLPMDFF 221
>IMGA|Medtr4g135780.1 Beta-Ig-H3/fasciclin
chr04_pseudomolecule_IMGAG_V3 33092789-33093987 E
EGN_Mt090430 20090702
Length = 292
Score = 141 bits (356), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 71/156 (45%), Positives = 103/156 (66%), Gaps = 2/156 (1%)
Query: 29 PAPSGPTNITAILEKAGQFTTFIKLMKSTQEADQINTQL-NNSNQGLTVFAPPDNAFANL 87
P SG +I IL KA F T I+L+K+TQ +Q+N QL N GLT+ AP D AF+ L
Sbjct: 70 PDASGNQDIIKILRKAKSFNTLIRLLKTTQIINQVNAQLVTTKNGGLTILAPDDGAFSEL 129
Query: 88 KPGTLNSLTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNVTTSGNQ 147
K G NSL ++ + +L+Q+H+LP +++ S F ++SNP+ T A +S G F +NVT GN
Sbjct: 130 KAGYFNSLGERQQKELIQYHVLPEYVSSSNFDSLSNPVLTLASDSPQG-FQINVTAYGNS 188
Query: 148 VNVTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDL 183
VN++TGV T+ +Y D +LA+Y V++VL+PLD
Sbjct: 189 VNISTGVVDTTITGIVYADKTLAIYHVNKVLIPLDF 224
>IMGA|Medtr2g021680.1 Beta-Ig-H3/fasciclin
chr02_pseudomolecule_IMGAG_V3 5565783-5564535 F
EGN_Mt090430 20090702
Length = 280
Score = 140 bits (353), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 78/180 (43%), Positives = 111/180 (61%), Gaps = 17/180 (9%)
Query: 36 NITAILEKAGQFTTFIKLMKSTQEADQINTQL-NNSNQGLTVFAPPDNAFANLKPGTLNS 94
+I IL KA F T I+L+K+TQ +QIN+QL N GLT+ AP D AF+ LK G NS
Sbjct: 68 DIIKILRKAKSFNTLIRLLKTTQIINQINSQLVTTKNGGLTILAPDDGAFSQLKAGYFNS 127
Query: 95 LTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNVTTSGNQVNVTTGV 154
L + + +L+QFH+LP +++ S F ++SNP+ T A +S +G + +NVT GN VN++TG
Sbjct: 128 LGEHQQKELIQFHVLPVYVSSSNFDSLSNPVLTLASDSPSG-YHMNVTAYGNNVNISTGP 186
Query: 155 DTATVANTIYTDGSLAVYQVDQVLLPLDLFGXXXXXXXXXSKPDEDTP----VKSPAAGK 210
AT+ +Y+D +LA+Y VD+VL+PLD SKP P K+P A K
Sbjct: 187 VNATLTGIVYSDKTLAIYHVDKVLIPLDF-----------SKPKALAPAPSTAKAPKADK 235
>IMGA|Medtr2g021670.1 Beta-Ig-H3/fasciclin
chr02_pseudomolecule_IMGAG_V3 5562881-5561707 E
EGN_Mt090430 20090702
Length = 277
Score = 139 bits (351), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 70/149 (46%), Positives = 102/149 (68%), Gaps = 2/149 (1%)
Query: 36 NITAILEKAGQFTTFIKLMKSTQEADQINTQL-NNSNQGLTVFAPPDNAFANLKPGTLNS 94
+I IL KA F T I+L+K+TQ +QIN+QL N GLT+ AP D AF LK G NS
Sbjct: 68 DIIKILRKAKSFNTLIRLLKTTQIINQINSQLVTTKNGGLTILAPDDGAFLQLKAGYFNS 127
Query: 95 LTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNVTTSGNQVNVTTGV 154
L ++ + +L+QFH+LP +++ S F ++SNP+ T A +S +G + +NVT GN VN++TG
Sbjct: 128 LGERQQKELIQFHVLPVYVSSSNFDSLSNPVLTLASDSPSG-YHMNVTAYGNNVNISTGP 186
Query: 155 DTATVANTIYTDGSLAVYQVDQVLLPLDL 183
AT+ +Y+D +LA+Y VD+VL+PLD
Sbjct: 187 VNATLTGIVYSDKTLAIYHVDKVLIPLDF 215
>IMGA|Medtr2g110640.1 Beta-Ig-H3/fasciclin
chr02_pseudomolecule_IMGAG_V3 26084116-26086419 E
EGN_Mt090430 20090702
Length = 293
Score = 137 bits (344), Expect = 6e-33, Method: Compositional matrix adjust.
Identities = 68/146 (46%), Positives = 103/146 (70%), Gaps = 2/146 (1%)
Query: 36 NITAILEKAGQFTTFIKLMKSTQEADQINTQL-NNSNQGLTVFAPPDNAFANLKPGTLNS 94
+I IL++A F F++LMK+TQ +Q+N+QL + GLT+ AP D+AF+ LKPG LNS
Sbjct: 69 DIVQILKQANSFNIFLRLMKTTQLINQLNSQLLTIKSGGLTILAPDDSAFSELKPGFLNS 128
Query: 95 LTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNVTTSGNQVNVTTGV 154
L+++ K++L+QFH++ F++ S F T++NP+RT AGN G+ LNV + G VN++TG
Sbjct: 129 LSNEKKLELLQFHVISDFVSSSNFDTLTNPVRTLAGNKP-GKVELNVISYGGNVNISTGS 187
Query: 155 DTATVANTIYTDGSLAVYQVDQVLLP 180
T+ IYTD LA+Y+V +VL+P
Sbjct: 188 VNTTINGIIYTDKHLAIYKVGKVLIP 213
>IMGA|Medtr5g105700.1 Beta-Ig-H3/fasciclin
chr05_pseudomolecule_IMGAG_V3 42474067-42476103 E
EGN_Mt090430 20090702
Length = 262
Score = 105 bits (262), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 54/150 (36%), Positives = 89/150 (59%), Gaps = 2/150 (1%)
Query: 36 NITAILEKAGQFTTFIKLMKSTQEADQINTQLNNSNQGLTVFAPPDNAFANLKPGTLNSL 95
N+T +L AG F TF++ ++ST+ D Q NN+ +G+T+F P D++FA+LK +L+ L
Sbjct: 48 NLTELLTVAGPFHTFLQYLQSTKVLDTFQNQANNTEEGITIFVPKDSSFASLKKPSLSKL 107
Query: 96 TDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQAGNSANGEFPLNVTTSGNQVNVTTGVD 155
D Q++ FH LP F +++ F+ +S T A G++ LN T + V + +G
Sbjct: 108 KDDEIKQVILFHALPHFYSLADFKNLSQTASTP--TFAGGDYTLNFTDNSGTVKINSGWS 165
Query: 156 TATVANTIYTDGSLAVYQVDQVLLPLDLFG 185
V + ++ +A+YQVD+VLLP +FG
Sbjct: 166 ITKVTSAVHATDPVAIYQVDKVLLPEAIFG 195
>IMGA|Medtr5g106070.1 Beta-Ig-H3/fasciclin
chr05_pseudomolecule_IMGAG_V3 42633668-42631976 E
EGN_Mt090430 20090702
Length = 421
Score = 65.9 bits (159), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 49/164 (29%), Positives = 83/164 (50%), Gaps = 13/164 (7%)
Query: 24 AQNPSPAPSGPTNITAILEKAGQFTTFIKLMKSTQEADQINTQLNNSNQGLTVFAPPDNA 83
A+ P+ APS ++ I+ K G +F L++ ++ + T + + GLTVF P D A
Sbjct: 185 AEAPTAAPS-DIDLIGIMSKQG-CQSFADLLRVSK---ALPTFKESVDGGLTVFCPTDTA 239
Query: 84 FANLKPGTLNSLTDQGKVQLVQFHILPSFIAMSQFQT---VSNPLRTQAGNSANGEFPLN 140
+ N LTD KV L+ +H +P + ++ ++ V N L T+ N ++
Sbjct: 240 VSGFSAKYKN-LTDSQKVSLLLYHGVPVYQSLQMLKSNNGVMNTLATEGHN----KYDFT 294
Query: 141 VTTSGNQVNVTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDLF 184
V G VN+ T V+TA + T+ VY++ +VL+P +LF
Sbjct: 295 VQNDGEDVNLETKVNTANIVGTLIDQDPFVVYKISKVLMPRELF 338
>IMGA|Medtr2g021940.1 Beta-Ig-H3/fasciclin
chr02_pseudomolecule_IMGAG_V3 5749971-5752637 E
EGN_Mt090430 20090702
Length = 244
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 36 NITAILEKAGQFTTFIKLMKSTQEADQINTQLNNSNQGLTVFAPPDNAFANLKPG-TLNS 94
N+T IL + F S +I+T+ + TVF P D AFAN S
Sbjct: 39 NLTKILYSSHTFFKAASEFHSLGIDSEIDTRYST-----TVFVPDDKAFANATVSKRYES 93
Query: 95 LTDQGKVQLVQFHILPSFIAMSQFQTVSNPLRTQ--AGNSANGE--FPLNVTTSGN-QVN 149
L+D K +++ H+L ++ + + ++N + Q G+ + +N+T N V
Sbjct: 94 LSDDNKYFVLKCHMLKEYLPPAVLRKIANDMHLQDTVATEIMGQATYRINITVMVNGSVA 153
Query: 150 VTTGVDTATVANTIYTDGSLAVYQVDQVLLPLDL 183
V+ + A V T+Y +AVY V +VL+P +L
Sbjct: 154 VSNNIVRALVTRTLYDRSPIAVYAVSKVLMPKEL 187